NYSE:CANO

NYSE Suspends Trading in Cano Health, Inc. (CANO) and Commences Delisting Proceedings

Retrieved on: 
Monday, February 5, 2024
United States bankruptcy court, Common stock, Bankruptcy

MIAMI, Feb. 5, 2024 /PRNewswire/ -- Cano Health, Inc. (NYSE: CANO) ("Cano Health" or the "Company") announced today that on February 5, 2024, the New York Stock Exchange (the "NYSE") notified the Company that the NYSE had determined to (a) commence proceedings to delist the Company's Class A common stock, par value $0.01 per share ("Common Stock") and (b) immediately suspend trading in the Company's Common Stock pursuant to Section 802.01D of the NYSE Listed Company Manual after the Company filed voluntary petitions for relief under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware on February 4, 2024.

Key Points: 
  • MIAMI, Feb. 5, 2024 /PRNewswire/ -- Cano Health, Inc. (NYSE: CANO) ("Cano Health" or the "Company") announced today that on February 5, 2024, the New York Stock Exchange (the "NYSE") notified the Company that the NYSE had determined to (a) commence proceedings to delist the Company's Class A common stock, par value $0.01 per share ("Common Stock") and (b) immediately suspend trading in the Company's Common Stock pursuant to Section 802.01D of the NYSE Listed Company Manual after the Company filed voluntary petitions for relief under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware on February 4, 2024.
  • The NYSE will apply to the U.S. Securities and Exchange Commission to delist the Company's Common Stock upon completion of all applicable procedures.
  • The Company does not intend to appeal the NYSE's determination and therefore expects that its Common Stock will be delisted from the NYSE.

Thinking about buying stock in Cano Health, Vaxart, Macy's, Albemarle Corp, or BioXcel Therapeutics?

Retrieved on: 
Monday, February 5, 2024
Multimedia

Each stock is evaluated based on short-term technical, long-term technical and fundamental factors.

Key Points: 
  • Each stock is evaluated based on short-term technical, long-term technical and fundamental factors.
  • Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.
  • InvestorsObserver provides patented technology to some of the biggest names on Wall Street and creates world-class investing tools for the self-directed investor on Main Street.
  • We have a wide range of tools to help investors make smarter decisions when investing in stocks or options.

Cano Health Announces Appointment of Two New Independent Directors

Retrieved on: 
Monday, December 18, 2023
Sale, Audit committee, Chair, Operational definition, Record, Ferrari, Committee on Finance, Management, Compensated emancipation

MIAMI, Dec. 18, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company") (NYSE: CANO), a leading value-based primary care provider and population health company, today announced the appointment of Patricia Ferrari and Carol Flaton to its Board of Directors. Ms. Ferrari and Ms. Flaton bring broad business experience and deep financial expertise, with proven track records of advising companies on strategies to improve operations and financial performance, as well as strengthening their capital structures.

Key Points: 
  • Patricia Ferrari and Carol Flaton to Enhance the Board's and Management's Ongoing Strategic, Operational and Financing Initiatives
    MIAMI, Dec. 18, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company") (NYSE: CANO), a leading value-based primary care provider and population health company, today announced the appointment of Patricia Ferrari and Carol Flaton to its Board of Directors.
  • Ms. Ferrari and Ms. Flaton bring broad business experience and deep financial expertise, with proven track records of advising companies on strategies to improve operations and financial performance, as well as strengthening their capital structures.
  • The Board has appointed Ms. Ferrari and Ms. Flaton, along with current director Angel Morales, to serve on the Finance Committee, with Ms. Flaton serving as Chair.
  • The Board also appointed Ms. Flaton as a member of the Board's Audit Committee and Ms. Ferrari to serve on the Compensation Committee.

Cano Health Announces Date to Report Third Quarter 2023 Results

Retrieved on: 
Wednesday, November 1, 2023
Conference, CANO, NYSE, Webcast, Rare-earth element, Shipbuilding

MIAMI, Nov. 1, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company") (NYSE: CANO), a leading value-based primary care provider and population health company, will release its financial results for the third quarter 2023 after the market closes on Thursday, November 9, 2023, and will host a conference call at 5:00 PM Eastern Time the same day to review its business and financial results.

Key Points: 
  • MIAMI, Nov. 1, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company") (NYSE: CANO), a leading value-based primary care provider and population health company, will release its financial results for the third quarter 2023 after the market closes on Thursday, November 9, 2023, and will host a conference call at 5:00 PM Eastern Time the same day to review its business and financial results.
  • To access the live call and webcast, please dial (888) 660-6359 for U.S. participants, or (929) 203-0867 for international participants, referencing the Cano Health Third Quarter 2023 Earnings Conference Call and Conference ID 8371699.
  • The call will also be webcast live in the "Events & Presentations" section of Cano Health's investor relations website ( investors.canohealth.com ).
  • A replay will be available in the same section of the Cano Health website for on-demand listening shortly after the completion of the call.

Cano Health Announces Change in Chief Financial Officer Role

Retrieved on: 
Friday, September 29, 2023
Interim, Florida International University, Professional, Frankfurt School of Finance & Management, Blue Cross Blue Shield Association, History of Florida International University, Humana, Certification, Medicare, Eladio, Interim management, Secretary of State of Florida, School, CPA, CANO, CFO, NYSE, Management

MIAMI, Sept. 29, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health") (NYSE: CANO) today announced that Eladio Gil has been appointed Interim Chief Financial Officer, effective September 29, 2023. Mr. Gil, who previously served as Cano Health's Vice President of Medicare Advantage Finance, succeeds Brian Koppy, who has stepped down to accept an opportunity outside the organization.

Key Points: 
  • MIAMI, Sept. 29, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health") (NYSE: CANO) today announced that Eladio Gil has been appointed Interim Chief Financial Officer, effective September 29, 2023.
  • Before joining Cano Health, Mr. Gil served as the Chief Financial Officer of Total Health, where he managed the company's finance and accounting functions, as well as Management Services Organizations Operations.
  • Additionally, he has held key finance and business leadership roles with other major healthcare companies, including as Chief Financial Officer of CarePlus Health and as Vice President of Care Delivery with Humana.
  • "We are thrilled to welcome Eladio as Interim CFO," said Mark Kent, Chief Executive Officer of Cano Health.

Cano Health sells substantially all of its Primary Care Centers in Texas & Nevada to CenterWell Senior Primary Care

Retrieved on: 
Tuesday, September 26, 2023
CANO, Borrowing base, Sale, Patient, NYSE, Credit Suisse, Bank

MIAMI, Sept. 26, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health") (NYSE: CANO) today announced that it sold substantially all of the assets associated with the operation of Cano Health's senior-focused primary care centers in Texas and Nevada to CenterWell Senior Primary Care ("CenterWell").

Key Points: 
  • MIAMI, Sept. 26, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health") (NYSE: CANO) today announced that it sold substantially all of the assets associated with the operation of Cano Health's senior-focused primary care centers in Texas and Nevada to CenterWell Senior Primary Care ("CenterWell").
  • As of August 1, 2023, the primary care centers in Texas and Nevada cared for approximately 15,200 members.
  • We appreciate CenterWell recognizing the value that Cano Health created in Texas and Nevada and look forward to them continuing to deliver high quality care for our patients there."
  • Following the transaction, Cano Health has available liquidity consisting of approximately $109 million of unrestricted cash.

Cano Health Appoints Mark Kent Permanent Chief Executive Officer

Retrieved on: 
Monday, August 21, 2023
Alameda County Board of Supervisors, Kent, Management

MIAMI, Aug. 21, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company"), a leading value-based primary care provider and population health company, today announced that its Board of Directors has appointed Mark Kent as Chief Executive Officer, effective immediately. The Board also elected Mr. Kent, who has served as interim Chief Executive Officer since June 16, 2023, to Cano Health's Board of Directors. The Board also announced that Dr. Marlow Hernandez has stepped down from the Board effective immediately.

Key Points: 
  • Mr. Kent immediately joins Board of Directors, replacing Dr. Marlow Hernandez who has stepped down
    MIAMI, Aug. 21, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company"), a leading value-based primary care provider and population health company, today announced that its Board of Directors has appointed Mark Kent as Chief Executive Officer, effective immediately.
  • The Board also elected Mr. Kent, who has served as interim Chief Executive Officer since June 16, 2023, to Cano Health's Board of Directors.
  • The Board also announced that Dr. Marlow Hernandez has stepped down from the Board effective immediately.
  • Regarding Mr. Kent's appointment, the Board issued the following statement:
    "Over the past several months, Mark Kent has demonstrated that he is the right person to lead Cano Health during this important period.

Cano Health Reschedules Second Quarter 2023 Earnings Conference Call

Retrieved on: 
Wednesday, August 9, 2023
CANO, Webcast, Conference, NYSE, Rare-earth element, Shipbuilding

MIAMI, Aug. 9, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company") (NYSE: CANO), announced today that it has rescheduled its second quarter 2023 earnings release and conference call to tomorrow afternoon.

Key Points: 
  • MIAMI, Aug. 9, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company") (NYSE: CANO), announced today that it has rescheduled its second quarter 2023 earnings release and conference call to tomorrow afternoon.
  • To access the live call and webcast, please dial (888) 660-6359 for U.S. participants, or (929) 203-0867 for international participants, referencing the Cano Health Second Quarter 2023 Earnings Conference Call and Conference ID 8371699.
  • The call will also be webcast live in the "Events & Presentations" section of Cano Health's investor relations website ( investors.canohealth.com ).
  • A replay will be available in the same section of the Cano Health website for on-demand listening shortly after the completion of the call.

Cano Health Announces Date to Report Second Quarter 2023 Results

Retrieved on: 
Tuesday, July 25, 2023
CANO, Webcast, Conference, NYSE, Oyster farming, Shipbuilding

MIAMI, July 25, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company") (NYSE: CANO), a leading value-based primary care provider and population health company, will release its financial results for the second quarter 2023 after the market closes on Wednesday, August 9, 2023, and will host a conference call at 5:00 PM Eastern Time the same day to review its business and financial results.

Key Points: 
  • MIAMI, July 25, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company") (NYSE: CANO), a leading value-based primary care provider and population health company, will release its financial results for the second quarter 2023 after the market closes on Wednesday, August 9, 2023, and will host a conference call at 5:00 PM Eastern Time the same day to review its business and financial results.
  • To access the live call and webcast, please dial (888) 660-6359 for U.S. participants, or (929) 203-0867 for international participants, referencing the Cano Health Second Quarter 2023 Earnings Conference Call and Conference ID 8371699.
  • The call will also be webcast live in the "Events & Presentations" section of Cano Health's investor relations website ( investors.canohealth.com ).
  • A replay will be available in the same section of the Cano Health website for on-demand listening shortly after the completion of the call.

Concerned Shareholders of Cano Health Condemn the Board’s Egregious Conduct and Unwillingness to Accept a Resounding Rebuke at the 2023 Annual Meeting

Retrieved on: 
Monday, July 17, 2023
Finance, Other Health, Health, Professional Services, Other Professional Services, Executive, Employment, Face, Public opinion, Disclosure, Annual Meetings of the International Monetary Fund and the World Bank Group, Russell 3000 Index, Million Pound Menu, 2021 Libertarian National Committee chair special election, Audit committee, MSP, Committee, Council of Institutional Investors, Russell, Hearing, Council, Annual general meeting, CANO, Ethics, Rivera, NYSE, Weil, Gotshal & Manges, Compensated emancipation, Holding company, Management, Security (finance), Shareholder

The three of us hold an approximately 35% equity stake in Cano, making our Group the largest stockholder of the Company.

Key Points: 
  • The three of us hold an approximately 35% equity stake in Cano, making our Group the largest stockholder of the Company.
  • We encourage Mark Kent, Cano’s interim Chief Executive Officer, and his team to focus on achieving efficiencies, eliminating excesses and executing a more focused strategy.
  • The Board has disregarded the unambiguous results of the Annual Meeting, where more than 82% of the votes cast WITHHELD support for Dr. Alan Muney and Kim Rivera.
  • The Board continues to keep in place Sol Trujillo as Chairman and Angel Morales as Chair of the Audit Committee.